Journal article · 2025 · Open access
Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species
Journal of Translational Medicine, 23(1), 605 · Published 30 May 2025 · DOI 10.1186/s12967-025-06572-6
In brief
“Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species” is a 2025 journal article by Cynthia J. Siebrand and 4 co-authors, published in Journal of Translational Medicine. OpenAlex counts 15 citations as of 18 November 2026, which puts it in the top 4% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Journal of Translational Medicine.
- Citations
- 15
- Most cited in
- 2026 (11)
- Field-weighted impact
- 4.13
- References
- 54
- Authors
- 5
Abstract
The lack of a definitive cure for Alzheimer's disease (AD) is fueling the search for innovative therapeutic strategies. Having revolutionized cancer immunotherapy, immune cell engineering with chimeric antigen receptors (CAR) is being explored to target AD. Whether CARs can recognize distinct amyloid-β (Aβ) species and tau neurofibrillary tangles (NFTs)—hallmark pathologies of AD—remains unclear. To investigate this, we engineered a series of CARs using single-chain fragment variable (scFv) derived from the variable light and heavy chains of antibodies tested in AD clinical trials. These included E2814 (E2814-CAR), targeting tau; Lecanemab (Lec-CAR) and Aducanumab (Adu-CAR), targeting Aβ; and Donanemab (Don-CAR) and Remternetug (Rem-CAR), targeting the truncated pyroglutamated Aβ species Aβp3–42. To evaluate CAR function, we utilized the murine DO11.10 CD4⁺ T-cell hybridoma line as a scalable and reproducible platform. CAR activation was assessed in response to tau preformed fibrils (PFFs), Aβ 1–42 oligomer-enriched aggregates, and Aβp3–42 aggregates, using flow cytometry for CD69 expression and ELISA for IL-2 secretion. To validate this platform, we tested Adu-CAR in primary mouse CD4⁺ T cells treated with Aβ 1–42 aggregates and assessed activation via flow cytometry for CD69 and CD25 expression. DO11.10 cells expressing E2814-CAR—but not Lec-CAR—responded to tau PFFs. In contrast, cells expressing Adu-CAR, and to a lesser extent Lec-CAR—but not E2814-CAR—responded to Aβ 1–42 aggregates. For Aβp3–42 aggregates, Rem-CAR elicited the strongest response, followed by Adu-CAR, while E2814-CAR and Don-CAR showed no activation. The activation of Adu-CAR by Aβ 1–42 aggregates was recapitulated in primary CD4⁺ T cells, as measured by CD69 expression. Our findings demonstrate that CARs can detect and discriminate between tau PFFs, Aβ1-42, and Aβp3-42 aggregates. This highlights the potential of repurposing AD antibodies for CAR-based therapies to selectively target tau NFTs and distinct forms of Aβ senile plaques.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Siebrand, C. J., Bergo, N. J., Lee, S., Andersen, J. K., & Walton, C. C. (2025). Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species. Journal of Translational Medicine, 23(1), 605. https://doi.org/10.1186/s12967-025-06572-6
MLA 9
Siebrand, Cynthia J., et al. “Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species.” Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 605. https://doi.org/10.1186/s12967-025-06572-6.
Chicago
Siebrand, Cynthia J., Nicholas J. Bergo, Suckwon Lee, Julie Kay Andersen, and Chaska C. Walton. 2025. “Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species.” Journal of Translational Medicine 23 (1): 605. https://doi.org/10.1186/s12967-025-06572-6.
Harvard
Siebrand, C. J. et al. (2025) ‘Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species’, Journal of Translational Medicine, 23(1), p. 605. doi:10.1186/s12967-025-06572-6.
IEEE
C. J. Siebrand, N. J. Bergo, S. Lee, J. K. Andersen, and C. C. Walton, “Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species,” Journal of Translational Medicine, vol. 23, no. 1, p. 605, 2025, doi: 10.1186/s12967-025-06572-6.
BibTeX
@article{siebrand2025chimeric,
title = {{Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species}},
author = {Siebrand, Cynthia J. and Bergo, Nicholas J. and Lee, Suckwon and Andersen, Julie Kay and Walton, Chaska C.},
journal = {Journal of Translational Medicine},
year = {2025},
volume = {23},
number = {1},
pages = {605},
doi = {10.1186/s12967-025-06572-6},
url = {https://doi.org/10.1186/s12967-025-06572-6}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- chimeric antigen receptor
- Alzheimer's disease
- amyloid-beta
- tau protein
- neurofibrillary tangles
- scFv
- chimeric antigen receptor T cells
- lecanemab
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Siebrand, C. J., Bergo, N. J., Lee, S., Andersen, J. K., & Walton, C. C. (2025). Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species. Journal of Translational Medicine, 23(1), 605. https://doi.org/10.1186/s12967-025-06572-6
How many times has this paper been cited?
15 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Translational Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Cynthia J. Siebrand, Nicholas J. Bergo, Suckwon Lee, Julie Kay Andersen, Chaska C. Walton.
What is the DOI of this paper?
10.1186/s12967-025-06572-6, permanently at https://doi.org/10.1186/s12967-025-06572-6. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.